Article
CRISPR-Cas9 genome engineering as a novel prognostic tools for Prostate cancer: long non-coding RNAs the predictive diagnostic index of targeted liposomal-coated compounds in prostate cancer therapy
2022-05-03
Abstract excerpt
<title>Abstract</title> <p><bold>Background: </bold>CRISPR/Cas9 is a recently explored genomic editing system that has greatly altered the technique that scientists study genes and their functions in mammalian systems. Cas9 is regulated via guide RNAs that match the targeted DNA in cleavage to modify the respective gene. The incessant advancement in prostate cancer (PC) modeling has directed not only to innovate...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d8d11a6c-413b-57b7-b903-f05eb299e565
- DOI
- 10.21203/rs.3.rs-1541397/v1
